3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
1
Meningioma
1
Medulloblastoma
1
Interventions
Isotretinoin
3
imetelstat
2
Peripheral Blood Stem Cell Transplantation
2
Cyclophosphamide
2
thymoglobulin
1
pazopanib
1
naxitamab
1
lorukafusp alfa
1
liposomal doxorubicin
1
keyhole-limpet hemocyanin
1
fludarabine phosphate
1
fludarabine
1
defibrotide
1
arginyllysine
1
Whole-Body Irradiation
1
Whole Body Imaging
1
Vincristine
1
Vaccines
1
Tretinoin
1
Topotecan
1
Thiotepa
1
Therapeutics
1
Temozolomide
1
Tacrolimus
1
Stem Cell Transplantation
1
Spermine Synthase
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Pentetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Neuroblastoma
×
90Y-octreotide, DOTA-Tyr(3)-
×
Clear all
NCT03013387
2017-08-25
Dosimetry Guided PRRT With 90Y-DOTATOC
University of Iowa
Phase 2
Withdrawn